TL;DR
Semaglutide produced an average of 14.9% body weight loss over 68 weeks in the STEP-1 trial at the 2.4 mg dose. One-third of participants lost 20% or more. Semaglutide is the generic name for the active ingredient in Wegovy, Ozempic, and compounded formulations.
Below you will find dose breakdowns, month-by-month timelines, side effect data, and a comparison of brand vs compounded options.
Semaglutide is the most widely prescribed GLP-1 receptor agonist for weight loss, and the clinical evidence behind it is extensive. You may know it by its brand names, Wegovy and Ozempic, or you may be considering compounded semaglutide as a more affordable alternative. Regardless of the formulation, the active molecule is the same.
Understanding semaglutide before and after data starts with the STEP clinical trial program. These four major studies enrolled thousands of participants and measured weight loss over more than a year. The results established semaglutide as one of the most effective non-surgical weight management tools available.
How Much Weight Do People Lose on Semaglutide?
The STEP-1 trial demonstrated 14.9% average body weight loss with semaglutide 2.4 mg weekly over 68 weeks, compared to 2.4% with placebo. The study enrolled 1,961 adults and was published in the New England Journal of Medicine. One-third of participants achieved weight loss of 20% or more.
For practical context, a 220-pound person losing 14.9% of body weight would lose roughly 33 pounds. A 260-pound person would lose roughly 39 pounds. These are averages, and individual results range widely based on starting weight, adherence, lifestyle factors, and genetics.
| Trial | Population | Duration | Avg Loss (Semaglutide 2.4 mg) | Avg Loss (Placebo) |
|---|---|---|---|---|
| STEP-1 | Obesity, no diabetes (n=1,961) | 68 weeks | 14.9% | 2.4% |
| STEP-2 | Obesity + type 2 diabetes (n=1,210) | 68 weeks | 9.6% | 3.4% |
| STEP-3 | With intensive behavioral therapy (n=611) | 68 weeks | 16.0% | 5.7% |
| STEP-4 | Continuation vs withdrawal (n=902) | 68 weeks | Continued: additional 7.9% | Placebo switch: ~7% regain |
The response rates are equally important. In STEP-1, 86.4% of participants on semaglutide lost at least 5% of body weight, 69.1% lost at least 10%, and 50.5% lost at least 15%. Those response rates are significantly higher than any previously approved weight loss medication.
What Is the Week-by-Week Semaglutide Timeline?
Semaglutide produces weight loss on a gradual curve, with the dose escalating from 0.25 mg to the full 2.4 mg over approximately 16 to 20 weeks. The most rapid weight loss typically occurs between months 3 and 8 of treatment. Appetite suppression begins almost immediately for most patients.
The titration schedule exists to minimize gastrointestinal side effects. Starting at the full dose would cause severe nausea in most patients. The gradual approach lets your body adapt while still producing meaningful early results.
| Timeframe | Dose | What to Expect | Estimated Cumulative Loss |
|---|---|---|---|
| Weeks 1 to 4 | 0.25 mg | Subtle appetite changes. Body adjusting. Minimal weight loss. | 1 to 2% |
| Weeks 5 to 8 | 0.5 mg | Appetite suppression becomes noticeable. Portion sizes decrease naturally. | 2 to 4% |
| Weeks 9 to 12 | 1.0 mg | Clear weight loss underway. Clothes fit differently. Cravings reduce. | 4 to 7% |
| Weeks 13 to 16 | 1.7 mg | Entering rapid loss phase. Side effects begin stabilizing. | 6 to 9% |
| Weeks 17 to 20 | 2.4 mg | Full dose reached. Maximum appetite suppression. | 8 to 11% |
| Weeks 21 to 40 | 2.4 mg | Peak weight loss period. Significant body composition changes. | 11 to 15% |
| Weeks 41 to 68 | 2.4 mg | Loss slows toward plateau. Maintenance phase begins. | 14 to 17% |
Not everyone follows this exact timeline. Patients with type 2 diabetes tend to lose weight more slowly. Those with higher starting BMIs often see faster initial losses.
The key factor is consistency: staying on the medication and following through with lifestyle changes.
What Are Semaglutide Side Effects?
Gastrointestinal side effects are the most common and most discussed aspect of semaglutide treatment. In the STEP-1 trial, 44% of participants reported nausea, 30% diarrhea, 24% vomiting, and 24% constipation. These numbers are higher than those reported for tirzepatide in the SURMOUNT trials.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →Context matters when reading those numbers. Most side effects were rated mild to moderate. They were concentrated during dose escalation periods and improved as the body adjusted.
Only 7% of participants discontinued semaglutide due to side effects.
| Side Effect | Semaglutide 2.4 mg | Placebo | Typical Duration |
|---|---|---|---|
| Nausea | 44% | 18% | 2 to 6 weeks per dose step |
| Diarrhea | 30% | 16% | 1 to 3 weeks |
| Vomiting | 24% | 6% | 1 to 2 weeks per dose step |
| Constipation | 24% | 11% | Variable, may persist |
| Abdominal pain | 20% | 11% | 2 to 4 weeks |
| Headache | 14% | 12% | 1 to 2 weeks |
| Fatigue | 11% | 5% | 2 to 4 weeks |
Strategies for managing side effects include eating smaller meals, avoiding high-fat foods during dose escalation, staying hydrated, and timing injections before bed so nausea occurs during sleep. Your prescribing physician can also slow the titration schedule if side effects are severe.
How Does Semaglutide Compare to Tirzepatide?
Tirzepatide (Mounjaro/Zepbound) has produced greater average weight loss in clinical trials: 20.9% vs 14.9% at their respective maximum doses. The difference is driven by tirzepatide's dual GIP/GLP-1 receptor mechanism versus semaglutide's GLP-1-only approach.
However, semaglutide has several practical advantages. It has been on the market longer, with more published long-term safety data. Compounded semaglutide is available at a lower price point than compounded tirzepatide ($199/mo vs $249/mo at FormBlends).
And some patients simply respond better to semaglutide.
| Feature | Semaglutide 2.4 mg | Tirzepatide 15 mg |
|---|---|---|
| Mechanism | GLP-1 only | Dual GIP/GLP-1 |
| Avg weight loss | 14.9% | 20.9% |
| Nausea rate | 44% | 24% |
| Time on market | Since 2021 (weight loss) | Since 2023 (weight loss) |
| Compounded cost (FormBlends) | $199/mo | $249/mo |
| Long-term safety data | More extensive | Growing |
Neither medication is universally superior. The right choice depends on your health profile, budget, tolerance, and treatment goals. Compare all GLP-1 options without insurance here.
Compounded vs Brand-Name Semaglutide: What Is the Difference?
Compounded semaglutide contains the same active ingredient as Wegovy and Ozempic, prepared by a licensed compounding pharmacy rather than the brand-name manufacturer (Novo Nordisk). The FDA has permitted compounding of semaglutide during shortage periods, and compounding pharmacies operate under state and federal regulations with strict quality standards.
The primary difference is cost. Brand-name Wegovy runs approximately $1,300 per month without insurance. Compounded semaglutide through FormBlends is $199 per month, which includes the medication, physician consultation, and shipping.
| Feature | Wegovy (Brand) | Compounded Semaglutide (FormBlends) |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Monthly cost (no insurance) | ~$1,300 | $199 |
| Administration | Pre-filled pen | Vial + syringe or pen |
| Available doses | 0.25 to 2.4 mg | Custom dosing available |
| Physician oversight | Required | Included |
| Insurance accepted | Varies by plan | Not applicable (cash pay) |
| FDA-approved product | Yes | FDA-regulated compounding |
Compounded semaglutide is the most popular option for patients without insurance coverage or with high copays for brand-name products. The clinical approach is identical: same active ingredient, same dosing schedule, same physician supervision. Compare compounded semaglutide options and pricing here.
What Do the STEP Clinical Trials Show?
The STEP program comprises four landmark trials that collectively enrolled over 4,500 participants and established semaglutide as a first-line treatment for obesity. Each trial was placebo-controlled, double-blinded, and published in peer-reviewed journals including the New England Journal of Medicine and The Lancet.
STEP-1 set the benchmark: 14.9% average body weight loss with semaglutide 2.4 mg over 68 weeks. STEP-2 showed 9.6% loss in patients with type 2 diabetes. STEP-3 demonstrated that adding intensive behavioral therapy boosted results to 16.0%.
And STEP-4 proved that stopping semaglutide leads to substantial weight regain.
The STEP-4 finding is critically important. Patients who continued semaglutide after an initial 20-week treatment period lost an additional 7.9% of body weight. Those who switched to placebo regained about two-thirds of their lost weight.
This data supports the medical consensus that obesity is a chronic disease requiring ongoing treatment, not a short-term condition that can be "cured" with a temporary medication course.
How to Maximize Semaglutide Results
STEP-3 showed that combining semaglutide with intensive behavioral therapy produced 16.0% body weight loss versus 14.9% with standard counseling alone. While one percentage point may sound small, it represents meaningful additional weight loss at scale and demonstrates that lifestyle factors matter even when medication is doing much of the heavy lifting.
The three most impactful lifestyle factors based on published data and our clinical experience at FormBlends are protein intake, resistance training, and sleep quality.
Protein first. Aim for 1.0 to 1.2 grams per kilogram of body weight daily, split across meals. This is the single most important dietary intervention for preserving lean muscle mass during GLP-1-mediated weight loss. Many patients undereat protein because their appetite is so suppressed.
Lift weights. Resistance training 2 to 3 times per week directly counteracts the lean mass loss that accompanies any significant weight reduction. You do not need a gym membership. Bodyweight exercises, resistance bands, or basic dumbbell routines all work.
Prioritize sleep. Poor sleep disrupts leptin and ghrelin, the hormones that regulate hunger and satiety. Patients who sleep less than 6 hours per night consistently see slower weight loss and more difficulty managing cravings, even on medication.
Model your projected timeline with the FormBlends weight loss calculator to set realistic monthly targets.
Frequently Asked Questions
What is the difference between semaglutide, Wegovy, and Ozempic?
Semaglutide is the active drug ingredient. Wegovy (semaglutide 2.4 mg) is FDA-approved for weight management. Ozempic (semaglutide 1.0/2.0 mg) is approved for type 2 diabetes but often prescribed off-label for weight loss.
Compounded semaglutide contains the same active ingredient from licensed compounding pharmacies.
How much weight can you lose on semaglutide?
The STEP-1 trial showed 14.9% average body weight loss over 68 weeks on semaglutide 2.4 mg. For a 220-pound person, that equals roughly 33 pounds. One-third of participants lost 20% or more of their starting weight.
How quickly does semaglutide work for weight loss?
Appetite changes typically begin within 1 to 2 weeks. Visible weight loss usually appears by weeks 4 to 8. Full therapeutic results take 6 to 12 months, as the dose is gradually escalated over the first 16 to 20 weeks.
Is compounded semaglutide as effective as Wegovy?
Compounded semaglutide contains the same active ingredient as Wegovy. When dosed at the same level (2.4 mg weekly) and obtained from a licensed compounding pharmacy, the clinical effect is expected to be equivalent. FormBlends works with pharmacies that undergo third-party purity testing.
What are semaglutide side effects?
The most common side effects are gastrointestinal: nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%) in the STEP-1 trial at the 2.4 mg dose. Side effects are typically worst during dose escalation and improve over time.
How much does compounded semaglutide cost?
Compounded semaglutide through FormBlends starts at $199 per month, compared to approximately $1,300 per month for brand-name Wegovy without insurance. The compounded version includes the same active ingredient with physician oversight and medication delivery.
What happens when you stop taking semaglutide?
Weight regain is common after stopping semaglutide. STEP-4 data showed patients who switched to placebo regained about two-thirds of their weight loss over 48 weeks. Most clinicians recommend ongoing treatment for sustained results.
Is semaglutide better than tirzepatide?
Tirzepatide has produced greater average weight loss in clinical trials: 20.9% vs 14.9%. However, semaglutide has a longer track record, more published safety data, and is available at a lower price as compounded semaglutide. The best choice depends on your individual health profile, goals, and budget.